To include your compound in the COVID-19 Resource Center, submit it here.

Public-private consortium launched to speed preclinical development

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), the University of California San Francisco and two national research laboratories

Read the full 153 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE